past
year
sever
coronavirus
cross
speci
barrier
human
caus
outbreak
sever
often
fatal
respiratori
ill
sinc
sarscov
first
identifi
anim
market
global
virom
project
discov
thousand
coronaviru
sequenc
divers
anim
geograph
region
unfortun
tool
avail
function
test
novel
virus
abil
infect
human
sever
hamper
effort
predict
next
zoonot
viral
outbreak
develop
approach
rapidli
screen
lineag
b
betacoronavirus
sarscov
recent
receptor
usag
abil
infect
cell
type
differ
speci
show
host
proteas
process
viral
entri
signific
barrier
sever
lineag
b
virus
bypass
barrier
allow
sever
lineag
b
virus
enter
human
cell
unknown
receptor
also
demonstr
differ
lineag
b
virus
recombin
gain
entri
human
cell
confirm
human
receptor
recent
emerg
authorfund
right
reserv
reus
allow
without
permiss
everi
year
addit
novel
cov
sequenc
discov
howev
massiv
knowledg
gap
field
littl
work
perform
viral
sequenc
publish
therefor
unknown
whether
novel
virus
potenti
emerg
human
popul
current
method
studi
novel
technic
demand
viral
isol
field
sampl
rare
success
revers
genet
recoveri
recombin
viru
laborintens
expens
synthesi
singl
genom
cost
upward
limit
prohibit
studi
novel
cov
scale
discov
cell
entri
essenti
compon
crossspeci
transmiss
especi
cov
encod
surfac
glycoprotein
spike
bind
hostcel
authorfund
right
reserv
reus
allow
without
permiss
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
receptor
mediat
viral
entri
singl
region
spike
protein
call
receptor
bind
domain
rbd
mediat
interact
host
cell
receptor
bind
receptor
nearbi
host
proteas
cleav
spike
releas
spike
fusion
peptid
facilit
viru
entri
known
host
receptor
includ
angiotensin
convert
enzym
sarscov
dipeptidyl
peptidas
merscov
structur
studi
coronavirus
shown
spike
rbd
capabl
fold
independ
rest
spike
protein
contain
structur
inform
host
receptor
bind
addit
previou
studi
show
replac
rbd
lineag
b
bat
viru
allow
viru
enter
cell
express
human
therefor
develop
method
function
test
rbd
novel
lineag
b
place
sarscov
spike
rbd
figur
synthes
rbd
spike
much
faster
costeffect
convent
pseudotyp
method
reli
synthesi
full
spike
sequenc
novel
cov
process
take
week
costprohibit
larg
panel
spike
sequenc
short
turnaround
time
approach
allow
us
test
receptor
usag
publish
uniqu
rbd
sequenc
lineag
b
also
rapidli
confirm
receptor
usag
spike
emerg
china
januari
studi
ongo
show
lineag
b
rbd
divid
function
distinct
clade
sever
previouslyunappreci
virus
exhibit
compat
unknown
receptor
human
cell
also
show
clade
capabl
recombin
impart
human
hostcel
entri
phenotyp
beyond
rdbreceptor
interact
host
authorfund
right
reserv
reus
allow
without
permiss
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
proteas
process
anoth
speci
barrier
encount
lineag
b
cell
entri
authorfund
right
reserv
reus
allow
without
permiss
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
bhk
vero
cell
maintain
dmem
sigma
supplement
fb
penicillinstreptomycin
lglutamin
ajprimari
aji
hypni
rhilu
rhini
cell
maintain
gibco
supplement
fb
penicillinstreptomycin
nonessenti
amino
acid
sodium
pyruv
lglutamin
ajprimari
cell
immort
lentivir
vector
express
tantigen
follow
manufactur
instruct
gener
aji
cell
abm
primari
cell
previous
describ
immort
studi
similar
aji
cell
spike
code
sequenc
sarscov
urbani
codon
optim
human
cell
append
kozak
express
sequenc
gccacc
tetraglycin
linker
follow
nucleotid
encod
flag
tag
sequenc
dykddddk
sarscov
spike
silent
mutat
introduc
around
codon
form
kpni
xhoi
digest
site
spike
silent
mutat
introduc
around
codon
form
aflii
hindiii
digest
site
spike
silent
mutat
introduc
around
codon
form
aflii
hindiii
digest
site
engin
spike
sequenc
synthes
clone
genscript
spike
rbd
first
codonoptim
human
cell
append
region
target
spike
backbon
facilit
infus
clone
synthes
doubl
authorfund
right
reserv
reus
allow
without
permiss
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
strand
dna
fragment
idt
dna
sarscov
engin
spike
plasmid
digest
correspond
restrict
enzym
gel
purifi
rbd
insert
resuspend
water
infus
clone
gel
purifi
digest
spike
backbon
vector
takara
human
apn
synthes
clone
genscript
dna
construct
verifi
sanger
sequenc
acgt
inc
bhk
cell
seed
black
plate
transfect
next
day
plasmid
dna
encod
human
apn
empti
vector
use
polyethyleneimin
polysci
downstream
experi
perform
hour
posttransfect
pseudotyp
produc
previous
describ
cell
seed
onto
plate
precoat
polyllysin
sigma
transfect
next
day
empti
plasmid
plasmid
encod
coronaviru
spike
gfp
pseudotyp
control
twentyfour
hour
later
transfect
cell
infect
particl
pseudotyp
vsvg
previous
describ
one
hour
incub
cell
wash
three
time
incub
dmem
supplement
fb
penicillinstreptomycin
lglutamin
hour
supernat
collect
centrifug
minut
aliquot
store
authorfund
right
reserv
reus
allow
without
permiss
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
target
cell
seed
black
plate
inocul
triplic
equival
volum
pseudotyp
stock
trypsin
experi
pseudotyp
stock
dilut
dmem
without
fb
trypsin
ad
final
concentr
sampl
incub
minut
sampl
dilut
cold
dmem
supplement
fb
ad
cell
inocul
plate
centrifug
hour
incub
night
approxim
hour
postinfect
brightglo
luciferas
reagent
promega
ad
well
without
remov
cultur
media
luciferas
measur
rel
entri
calcul
normal
rel
light
unit
rlu
spike
pseudotyp
plate
rlu
averag
pseudotyp
control
produc
cell
spiketransfect
lyse
sd
nacl
trishcl
edta
clarifi
centrifug
minut
pseudotyp
particl
concentr
produc
cell
lysat
overlaid
optiprep
cushion
pb
sigma
centrifug
g
hour
lysat
concentr
particl
analyz
flag
gapdh
andor
vsvm
express
bistri
page
gel
thermofish
access
number
spike
sequenc
use
found
figur
authorfund
right
reserv
reus
allow
without
permiss
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
receptor
bind
domain
rbd
lineag
b
singl
continu
domain
contain
structur
inform
necessari
interact
host
receptor
authorfund
right
reserv
reus
allow
without
permiss
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
bind
host
receptor
hostcel
proteas
cleav
spike
releas
fusion
peptid
allow
host
cell
entri
previou
studi
shown
absenc
host
proteas
incompat
host
proteas
viral
spike
block
viral
entri
circumv
hostcel
proteas
incompat
absenc
surprisingli
exogen
proteas
enhanc
entri
subset
clade
spike
chimera
nonhuman
primat
bat
human
cell
figur
importantli
vsvg
pseudotyp
particl
abl
produc
luciferas
signal
cell
line
test
studi
supp
fig
next
test
human
variant
known
receptor
abil
mediat
cell
entri
clade
spike
chimera
also
test
human
authorfund
right
reserv
reus
allow
without
permiss
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
importantli
absenc
receptor
entri
observ
pseudotyp
suggest
proteasemedi
entri
receptordepend
figur
right
panel
consensu
sequenc
three
lineag
b
clade
show
sever
key
differ
group
clade
rbd
contain
residu
shown
crystallographi
interact
human
figur
major
residu
absent
clade
contain
addit
delet
surfac
expos
loop
cluster
interfac
figur
b
gener
seri
clade
consensu
rbd
variant
determin
minimum
number
mutat
need
impart
function
clade
rbd
figur
introduc
two
loop
delet
clade
clade
result
reduc
spike
express
impair
pseudotyp
incorpor
loss
cell
entri
figur
authorfund
right
reserv
reus
allow
without
permiss
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
restor
loop
clade
loop
found
clade
enhanc
entri
figur
version
introduc
contact
point
clade
also
fail
restor
entri
figur
version
replac
contact
point
surround
amino
acid
also
known
receptor
bind
motif
rbm
lead
increas
entri
clade
rbd
figur
version
clade
residu
clade
residu
version
clade
residu
clade
residu
taken
togeth
result
show
entir
rbm
clade
need
entri
next
synthes
fulllength
clade
spike
compar
rbd
chimera
select
clade
spike
consist
gave
strong
entri
signal
human
cell
follow
proteasetreat
figur
well
clade
spike
panel
sarscov
spike
clade
spike
codon
optim
flagtag
silent
mutat
introduc
facilit
replac
rbd
consensu
rbd
clade
figur
chimer
construct
express
similarli
except
rbd
chimera
exhibit
reduc
express
incorpor
figur
proteas
treatment
enhanc
entri
clade
rbd
chimera
fulllength
spike
entri
huh
cell
figur
proteas
treatment
effect
either
clade
chimera
fulllength
spike
figur
taken
togeth
find
show
sarslineag
b
rbd
chimera
reflect
entri
phenotyp
fulllength
lineag
b
spike
authorfund
right
reserv
reus
allow
without
permiss
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
final
test
receptorbind
proteas
process
coupl
replac
rbd
fulllength
clade
spike
consensu
rbd
clade
test
pseudotyp
cell
express
clade
receptor
clade
consensu
rbd
effici
facilit
entri
spike
follow
proteas
treatment
find
show
even
though
cell
support
fulllength
clade
spike
entri
rbd
clade
viru
insuffici
mediat
entri
seen
previou
experi
proteas
treatment
enhanc
pseudotyp
entri
absenc
host
receptor
figur
authorfund
right
reserv
reus
allow
without
permiss
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
despit
signific
advanc
next
gener
sequenc
technolog
facilit
discoveri
thousand
novel
animalderiv
virus
tool
downstream
function
assess
novel
sequenc
lack
gain
traction
evergrow
problem
took
reductionist
approach
coronaviru
entri
develop
scalabl
method
test
minim
region
viru
essenti
interact
host
receptor
figur
figur
virus
never
isol
resort
synthet
biolog
molecular
engin
reduc
burden
gene
synthesi
small
fragment
thu
cost
synthesi
product
time
test
sever
spike
entri
system
dramat
reduc
figur
theori
approach
function
virom
applic
wide
varieti
virushost
protein
interact
coronaviru
entri
multistep
process
involv
multipl
distinct
domain
spike
mediat
viru
attach
cell
surfac
receptor
engag
proteas
process
membran
fusion
rbd
receptor
interact
studi
process
recent
studi
highlight
major
role
host
proteas
process
play
speci
barrier
lineag
c
coronavirus
includ
merscov
well
distantli
relat
virus
studi
shown
bind
human
requir
addit
exogen
trypsin
facilit
cell
entri
spike
enter
human
cell
unidentifi
receptor
proteas
treatment
analog
earlier
studi
lineag
c
cov
observ
proteaseenhanc
entri
lineag
b
cov
figur
shown
host
proteas
cleav
spike
allow
downstream
authorfund
right
reserv
reus
allow
without
permiss
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
membran
fusion
evid
suggest
proteas
may
act
receptor
well
activ
therefor
studi
need
assess
trypsin
enhanc
entri
coronavirus
level
spike
receptor
absenc
exogen
proteas
clade
rbd
enter
nonhuman
primat
human
porcin
cell
line
figur
b
b
find
strong
agreement
previou
studi
either
isol
viru
rescu
recombin
chimer
virus
howev
trypsin
subset
geneticallysimilar
clade
rbd
gain
entri
cell
suggest
barrier
level
proteas
process
figur
b
spike
clade
enter
cell
test
regardless
proteas
addit
suggest
absent
incompat
receptor
surprisingli
proteasedepend
entri
phenotyp
consist
revers
spike
chimera
replac
rbd
clade
spike
clade
rbd
figur
suggest
either
proteas
site
compat
chimer
spike
backbon
proteas
express
cell
figur
clade
spike
enter
cell
express
human
without
addit
proteas
chimera
requir
proteas
data
suggest
spike
proteas
cleavag
site
adapt
proteas
environ
receptorbound
rbd
figur
authorfund
right
reserv
reus
allow
without
permiss
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
none
spike
pseudotyp
effici
enter
rhinolophu
cell
observ
previou
studi
use
cell
figur
surprisingli
aji
cell
select
permiss
clade
entri
follow
proteas
treatment
suggest
clade
rbd
interact
receptor
distinct
clade
figur
result
show
despit
classifi
viru
speci
lineag
b
use
current
known
coronaviru
receptor
figur
b
critic
observ
pseudotyp
entri
presenc
proteas
absenc
receptor
suggest
lineag
b
cell
entri
still
receptordepend
follow
proteas
treatment
figur
studi
ongo
novel
lineag
b
identifi
etiolog
agent
behind
outbreak
pneumonia
wuhan
hubei
china
rbd
residu
motif
found
clade
form
distinct
clade
test
receptor
usag
observ
entri
human
known
coronaviru
receptor
figur
interestingli
within
backbon
sarscov
spike
cell
entri
similar
clade
spike
test
includ
sarscov
find
suggest
capabl
use
human
effici
sarscov
may
help
explain
humantohuman
transmiss
viru
studi
need
full
spike
sequenc
ideal
viral
isol
receptor
bind
motif
rbm
small
region
ctermin
half
rbd
contain
residu
interfac
host
receptor
figur
contact
point
costructur
sarsrbd
bound
human
larg
absent
clade
rbd
also
contain
delet
compar
clade
rbm
figur
b
simpli
mutat
clade
contact
point
authorfund
right
reserv
reus
allow
without
permiss
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
insuffici
impart
human
usag
figur
like
noncontact
residu
rbm
play
support
structur
role
contact
point
inde
noncontact
residu
differ
clade
figur
contrast
chang
individu
amino
acid
chimer
rbd
construct
show
clade
rbd
contain
clade
rbm
compat
human
coronavirus
frequent
undergo
recombin
gain
larg
swath
genet
materi
taken
togeth
data
possibl
recombin
clade
viru
impart
compat
human
interestingli
rbd
form
clade
distinct
clade
figur
howev
rbd
contain
contact
point
human
found
clade
well
amino
acid
variat
uniqu
clade
figur
taken
togeth
receptor
assay
result
may
possibl
aros
recombin
clade
clade
saw
rbd
clade
spike
chimera
full
length
spike
enter
cell
follow
proteas
treatment
clade
spike
figur
data
show
chimer
spike
gener
reproduc
entri
phenotyp
fulllength
spike
notabl
full
length
spike
enter
cell
effici
chimera
suggest
humancel
adapt
like
need
spike
capac
predict
zoonot
potenti
newli
detect
virus
sever
hinder
lack
function
data
novel
anim
viru
sequenc
develop
rapid
costeffect
platform
function
test
larg
group
relat
virus
zoonot
potenti
found
sever
lineag
b
authorfund
right
reserv
reus
allow
without
permiss
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
coronavirus
capabl
enter
human
cell
unknown
receptor
lineag
b
spike
protein
recombin
gain
entri
known
hostreceptor
taken
togeth
latest
outbreak
human
find
underscor
import
continu
surveil
coronavirus
sequenc
function
level
order
better
prepar
next
emerg
viru
replic
authorfund
right
reserv
reus
allow
without
permiss
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
replic
authorfund
right
reserv
reus
allow
without
permiss
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
replic
c
express
pseudotyp
incorpor
rbd
chimera
pseudotyp
use
infect
cell
express
hapn
empti
vector
without
proteas
treatment
authorfund
right
reserv
reus
allow
without
permiss
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
authorfund
right
reserv
reus
allow
without
permiss
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
authorfund
right
reserv
reus
allow
without
permiss
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
